Rockefeller Capital Management
CALC icon

Rockefeller Capital Management’s CalciMedica CALC Stock Holding History

Rockefeller Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7K Sell
5,000
-5,000
-50% -$10.1K ﹤0.01% 4361
2025
Q4 		$65.9K Hold
10,000
– – ﹤0.01% 2938
2025
Q3 		$30.8K Buy
+10,000
New +$28.8K ﹤0.01% 3138

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Rockefeller Capital Management's CALC Position: Q1 2026 in Review

Rockefeller Capital Management reduced its CalciMedica (CALC) stake by 50% in Q1 2026, selling an estimated $10.1K and leaving 5,000 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4361.

Rockefeller Capital Management first reported a position in CALC in Q3 2025 and has held it in 3 quarters since. The position peaked at $65.9K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Rockefeller Capital Management held 5,000 shares of CalciMedica worth $2.7K as of Q1 2026.
  • Rockefeller Capital Management sold 5,000 CalciMedica shares in Q1 2026, an estimated $10.1K.
  • CalciMedica made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4361 holding.
  • Rockefeller Capital Management first reported a position in CalciMedica in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's CalciMedica position peaked at $65.9K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.